Systemic mastocytosis as a risk factor for severe Hymenoptera sting-induced anaphylaxis.
暂无分享,去创建一个
A. Órfão | P. Bonadonna | L. Sánchez-Muñoz | I. Alvarez-Twose | A. Matito | J. M. Morgado | D. González-de-Olano | L. Escribano | R. Zanotti
[1] A. Kerstan,et al. Over- and underestimated parameters in severe Hymenoptera venom-induced anaphylaxis: cardiovascular medication and absence of urticaria/angioedema. , 2012, The Journal of allergy and clinical immunology.
[2] A. Órfão,et al. Validation of the REMA Score for Predicting Mast Cell Clonality and Systemic Mastocytosis in Patients with Systemic Mast Cell Activation Symptoms , 2011, International Archives of Allergy and Immunology.
[3] A. Órfão,et al. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms. , 2010, The Journal of allergy and clinical immunology.
[4] G. Passalacqua,et al. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels. , 2009, The Journal of allergy and clinical immunology.
[5] A. Órfão,et al. KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. , 2006, Blood.
[6] A. Órfão,et al. Immunophenotypic analysis of mast cells in mastocytosis: When and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA) , 2004, Cytometry. Part B, Clinical cytometry.
[7] A. Órfão,et al. Flow cytometric analysis of mast cells from normal and pathological human bone marrow samples: identification and enumeration. , 1996, The American journal of pathology.